Minneapolis Portfolio Management Group LLC lessened its stake in The Clorox Company (NYSE:CLX – Free Report) by 53.0% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 172,615 shares of the company’s stock after selling 194,774 shares during the period. Clorox comprises approximately 1.3% of Minneapolis Portfolio Management Group LLC’s portfolio, making the stock its 29th largest position. Minneapolis Portfolio Management Group LLC’s holdings in Clorox were worth $13,984,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Ancora Advisors LLC acquired a new position in Clorox during the second quarter worth $28,000. Avalon Trust Co acquired a new stake in shares of Clorox in the second quarter valued at $29,000. Markowski Investments acquired a new stake in shares of Clorox in the second quarter valued at $30,000. Pension & Wealth Management Advisors Inc. acquired a new stake in shares of Clorox in the third quarter valued at $26,000. Finally, Western Wealth Management LLC purchased a new stake in shares of Clorox in the 1st quarter valued at $35,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.
Clorox Stock Performance
NYSE:CLX opened at $109.35 on Monday. The company has a fifty day simple moving average of $88.75 and a two-hundred day simple moving average of $99.54. The company has a market cap of $13.25 billion, a price-to-earnings ratio of 19.67, a price-to-earnings-growth ratio of 3.46 and a beta of 0.59. The company has a quick ratio of 0.39, a current ratio of 0.65 and a debt-to-equity ratio of 32.91. The Clorox Company has a 52 week low of $79.12 and a 52 week high of $128.90.
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings data on Monday, November 2nd. The company reported $1.55 earnings per share for the quarter, topping analysts’ consensus estimates of $1.07 by $0.48. The business had revenue of $1.91 billion for the quarter, compared to analyst estimates of $1.88 billion. Clorox had a return on equity of 608.30% and a net margin of 9.41%. The company’s revenue was up 33.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.85 earnings per share. As a group, equities analysts anticipate that The Clorox Company will post 5.74 earnings per share for the current fiscal year.
Clorox Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, November 13th. Investors of record on Wednesday, October 28th were paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 4.6%. The ex-dividend date of this dividend was Wednesday, October 28th. Clorox’s payout ratio is presently 89.93%.
Analyst Upgrades and Downgrades
Several research firms recently issued reports on CLX. Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a research note on Tuesday, October 6th. Barclays lowered their target price on Clorox from $84.00 to $80.00 and set an “underweight” rating for the company in a report on Friday, October 16th. BNP Paribas Exane dropped their target price on Clorox from $97.00 to $95.00 and set a “neutral” rating for the company in a research report on Monday, July 20th. Morgan Stanley boosted their price target on shares of Clorox from $87.00 to $94.00 and gave the stock an “equal weight” rating in a research note on Wednesday, November 4th. Finally, Citigroup reduced their price target on shares of Clorox from $97.00 to $90.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 14th. One equities research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and four have given a Sell rating to the company. According to MarketBeat, Clorox presently has a consensus rating of “Reduce” and a consensus target price of $93.79.
Check Out Our Latest Stock Report on CLX
Insider Buying and Selling
In related news, Director Pierre Breber purchased 4,000 shares of the business’s stock in a transaction on Wednesday, November 4th. The shares were bought at an average price of $100.06 per share, for a total transaction of $400,240.00. Following the acquisition, the director directly owned 22,000 shares in the company, valued at $2,201,320. This trade represents a 22.22% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.51% of the stock is owned by insiders.
Clorox Company Profile
The Clorox Company is a consumer products company founded in 1913 and headquartered in Oakland, California. It makes and markets products for household cleaning, food, water filtration, personal care and pet care. Its portfolio includes Clorox disinfecting and cleaning products, Glad trash bags and food-storage products, Kingsford charcoal, Brita water filters, Hidden Valley dressings and sauces, Burt’s Bees personal-care products, and Fresh Step cat litter. The company also sells products under brands such as Pine-Sol and Liquid-Plumr.
Read More
- Five stocks we like better than Clorox
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
